×
About 30 results

ALLMedicine™ Angioimmunoblastic Lymphoma Center

Research & Reviews  11 results

Non-Hodgkin Lymphoma (NHL)
http://emedicine.medscape.com/article/203399-overview

Aug 3rd, 2021 - Practice Essentials Non-Hodgkin lymphomas (NHLs) are tumors originating from lymphoid tissues, mainly of lymph nodes. These tumors may result from chromosomal translocations, infections, environmental factors, immunodeficiency states, and chronic ...

Non-Hodgkin Lymphoma (NHL)
https://emedicine.medscape.com/article/203399-print

Aug 3rd, 2021 - Practice Essentials Non-Hodgkin lymphomas (NHLs) are tumors originating from lymphoid tissues, mainly of lymph nodes. These tumors may result from chromosomal translocations, infections, environmental factors, immunodeficiency states, and chronic ...

Allo-hNHL (FluBuCy)
https://clinicaltrials.gov/ct2/show/NCT00785330

Jan 13th, 2020 - Patients in the age of 18 to 65 years with a high- risk relapse of a histology proven aggressive Non-Hodgkin's-lymphoma are eligible for the trial. Aggressive Non-Hodgkin's lymphoma within this study is defined as: B-NHL: follicular lymphoma grade...

Breast Implant-Associated Bilateral B-Cell Lymphoma.
https://doi.org/10.1093/asj/sjy093
Aesthetic Surgery Journal; Chen VW, Hoang D et. al.

Apr 11th, 2018 - Lymphomas associated with implants are predominantly of T-cell type-with anaplastic large cell lymphoma (ALCL) being most reported. That said, to date, 6 cases of B-cell lymphoma associated with breast implants have been reported. All cases exhibi...

Lymphocytic interstitial pneumonia in children
https://www.uptodate.com//contents/lymphocytic-interstitial-pneumonia-in-children
Lisa R Young

INTRODUCTION Lymphocytic interstitial pneumonia (LIP) remains in the differential diagnosis for interstitial lung disease (ILD) in childhood, although it is actually a form of pulmonary lymphoproliferative disease. LIP may be part of a spectrum wi...

see more →

Clinicaltrials.gov  1 results

Allo-hNHL (FluBuCy)
https://clinicaltrials.gov/ct2/show/NCT00785330

Jan 13th, 2020 - Patients in the age of 18 to 65 years with a high- risk relapse of a histology proven aggressive Non-Hodgkin's-lymphoma are eligible for the trial. Aggressive Non-Hodgkin's lymphoma within this study is defined as: B-NHL: follicular lymphoma grade...

see more →